Normal and preganglionically denervated cat superior cervical ganglia were sectioned and cultured for 24 or 48 hr, with or without preliminary inactivation of acetylcholinesterase, and in the presence or absence of 10-5 M glycyl-L-glutamine. They were then homogenized, and the molecular forms of acetylcholinesterase were analyzed by sucrose gradient sedimentation. We observed an increased proportion of the globular monomeric G, form, and to a lesser extent of the dimeric G2 and tetrameric membranous G4 forms, of acetylcholinesterase in the glycyl-L-glutamine-treated compared with the control cultures. There was only a small increase in the total acetylcholinesterase activity and no significant variation in the activity of the metabolic enzyme lactate dehydrogenase. It therefore seems likely that glycyl-L-glutamine, or the endogenous neurotrophic factor, maintains acetylcholinesterase in the preganglionically denervated ganglia in vivo by specifically increasing the biosynthesis of the monomeric G, form, but not that of other proteins; these trophic factors do not seem to promote the polymerization of G, into the more complex G2 and G4 forms.
Preganglionic denervation of the cat superior cervical ganglion (SCG) results within a few days in a marked decrease in its contents of acetylcholinesterase (AcChoEase, EC 3.1.1.7) and butyrylcholinesterase (BtChoEase, EC 3.1.1.8) (1, 2) . In a recent series of experiments (1, (3) (4) (5) (6) it was shown that the 24-hr intracarotid infusion of a dialyzed aqueous extract of cat brain, spinal cord, and sciatic nerves, or of glycyl-L-glutamine (Gly-Gln), or of some closely related compounds, opposes the decrease of both enzymes. Gly-Gln was tested after the demonstration by Haynes and Smith (7) that this compound increases the formation of the G4 (globular tetramer) and A12 (collagen-tailed, asymmetric dodecamer) forms of AcChoEase (8) in cultured preparations of embryonic rat and chicken skeletal muscle.
In the present study we investigated the stage at which Gly-Gln, or the unidentified endogenous neurotrophic factor, enhances the production of AcChoEase in denervated ganglia. In an effort to study this effect in vitro, we first used whole desheathed rat SCG that had been preganglionically denervated one day previously. Results were suggestive, but equivocal, probably for the reasons given in the Discussion and, consequently, are not presented.
In the experiments reported here, sections of normal or preganglionically denervated cat SCG were incubated in culture medium for 24 or 48 hr, with or without inactivation of their initial AcChoEase content, and with or without the addition of Gly-Gln or nervous tissue extract. The SCGs were then homogenized in a high-salt and Triton X-100-containing extraction medium to solubilize AcChoEase. The molecular forms of the enzyme were analyzed by sedimentation in sucrose density gradients, as described previously (9) . METHODS We cultured sections of cat SCG with a number of variations: the interval between preganglionic denervation and excision, omission of denervation, time in culture, and inclusion or omission of near-total inactivation of AcChoEase and BtChoEase before culture. During the preceding in vivo studies cited, values for AcChoEase were far more consistent and exhibited greater modifications by various treatments than were those for BtChoEase. Therefore only the former enzyme was measured here.
After preliminary trials, we adopted the following general procedure. Cats were anesthetized with ketamine, 15 mg/kg, intramuscularly, and a 1-cm segment was resected from the right and left cervical sympathetic trunks; the operative wound was sutured and Combiotic (penicillin plus dihydrostreptomycin), 0.5 ml, was injected intramuscularly. One to five days later the cats were reanesthetized with sodium pentobarbital, 50 mg/kg, intraperitoneally; the SCG were excised, along with the stellate and ciliary ganglia for related studies; and blood was taken by cardiac puncture for separation of serum. The SCG were held in ice-cold Dulbecco's modified Eagle's medium for <2 hr, then desheathed, and sectioned transversely at 375 or 400 ,um with a McIlwaine tissue chopper. Six to nine uniform sections were obtained from each SCG. In some experiments the sections were incubated for 30 min at 5-70C with 10-5 M 217 AO [(2-mercaptoethyl)dimethylamine acid oxalate (Ayerst Laboratories, New York)], in the same medium, for irreversible inactivation of AcChoEase and BtChoEase. After a brief rinse in 0.9% NaCl solution, sections were held in the medium for '30 min at 50C before culture.
Sections were generally placed in 24-well culture dishes. Each well contained 1 ml of medium and received two sections. The culture medium was made up of the following ingredients for 100 ml: Dulbecco's modified Eagle's medium (80 ml); hormone mix (10 ml, to give final concentrations of transferrin at 100 ,ug/ml, insulin at 25 ,ug/ml, progesterone at Abbreviations: AcChoEase, acetylcholinesterase; BtChoEase, butyrylcholinesterase; Gly-Gln, glycyl-L-glutamine; SCG, superior cervical ganglion or ganglia; LDH, lactate dehydrogenase; 217 AO, (2-mercaptoethyl) containing 20%o glucose and Gly-Gln (experimentals) (10 ml); 200 mM glutamine (1 ml); and gentamicin at 10 mg/ml (1 ml). Three controls and three experimental preparations were generally incubated in each experiment. In some experiments, the final volume of identically prepared medium was 3.0 ml, to which six sections were added. The cultures were placed on a rocker (six oscillations per min) in an incubator at 370C and 7% C02/93% air for 24 or 48 hr. The sections from each well were then homogenized in 200-(or 600-) 1ul extraction buffer (1 M NaCl/1% Triton X-100/0.05 MgCl2/ 0.01 M Tris-HCI, pH 7.4/bacitracin at 0.1 mg/ml) in a conical glass-glass hand homogenizer. Homogenates were centrifuged at 10,000 x g for 15 min in a cold Eppendorf centrifuge; 100-pl samples of each supernatant were immediately layered on sucrose density gradients (5-20% wt/vol) of the same composition as the extraction medium. Escherichia coli alkaline phosphatase (6.1 S) and f3-galactosidase (16 S) were added to the samples as internal sedimentation standards. The gradients were centrifuged for 18 hr at 39,000 rpm in a Beckman SW 41 rotor at 4-50C. Approximately 42 fractions were collected and assayed by a modification of Ellman's method (10) as indicated previously (9) . Astra 1397
[10-(a-diethylaminoproprionyl)phenothiazine; Astra Lakemedel, Stockholm], I0-4 M, was added to the reaction mixture for the inhibition of BtChoEase. The reaction mixtures were held at room temperature for 60-400 min, and absorbance was read at identical intervals for each sample at 412 nm with a Gilford (Oberlin, OH) spectrophotometer. Results were calculated as nanomoles of acetylthiocholine hydrolyzed per fraction per hour for presentation in the figures. The protein concentration of extracts was determined with the method of Lowry et al. (11) or of Bradford (12) . The activities of lactate dehydrogenase (LDH) and enolase were determined as indicated previously (9) . An aqueous extract of cat central nervous system, which was used in a few experiments, was prepared and dialyzed exactly as described previously (1, 3) and was stored at -70°C.
RESULTS
Effects of Time Following Denervation on AcChoEase Contents and Molecular Forms of Cultured Sections of Cat SCG. Total AcChoEase. When AcChoEase was not inhibited before culture, we obtained a pattern of molecular forms that closely resembled that observed with freshly excised normal cat SCG (9) . The G4 form markedly predominated over the G1 and G2 forms, and there was an extremely small A12 peak ( Fig. 1, solid line) . The only notable difference was that in fresh homogenates of normal SCG the G1 peak predominated over the G2 peak, whereas the reverse was true in the 24-hr cultured sections, and the G1 form was represented only by a shoulder of the major G2 peak.
Sections of SCG excised 1 day after denervation and cultured for 24 hr ( Fig. 2A, solid line) showed practically identical molecular-form patterns as those of similarly treated nondenervated ganglia. All peaks were reduced by -25%.
When SCG were excised 3 days after denervation and cultured 24 hr, the total AcChoEase activity was approximately one-fifth that of sections from nondenervated SCG; however, the relative amounts of the various forms were approximately the same (Fig. 2B, solid line) . At 5 days after denervation, the total AcChoEase activity of 24-hr cultured sections was less than one-tenth that of normal SCG; the major fall was in the G4 peak (Fig. 2C, solid  line) . When culture was extended to 44 hr (Fig. 2D, solid  line) , all peaks were increased, especially the G4 peak, indicating that synthesis of AcChoEase still continued. Newly synthesized AcChoEase. Preliminary treatment of SCG sections with 217 AO, as described under Methods, was found to produce near-total, essentially permanent inactivation of AcChoEase and BtChoEase. Accordingly, all AcChoEase activity found after incubation represents enzyme synthesized in culture.
In sections of nondenervated SCG treated with 217 AO and cultured for 24 hr, the specific activity of AcChoEase was approximately one quarter that of untreated similar sections, and the proportions of molecular forms were similar (Fig. 1, broken line) -the major peaks being G4, G2, and G1. A reasonably high rate of synthesis therefore continued in vitro.
One day after denervation, 217 AO-treated sections cultured for 24 hr exhibited -40% of the total AcChoEase activity of similarly treated nondenervated SCG (Fig. 3A, solid line). When culture was extended to 48 hr, there was nearly a doubling of the G4 peak and minor changes in the G2 and G1 peaks (Fig. 3B, solid line) . Sections prepared from ganglia excised 3-5 days following denervation exhibited a drastic reduction in AcChoEase synthesis in culture, but within that period the situation remained fairly stable. At 5 days after denervation the amount synthesized was -5-10% of that produced by nondenervated SCG; the greatest reduction was in the G4 peak, with progressively less reduction in the G2 and G1 peaks (Fig. 3D , solid line; note 10-fold reduction in scale). The total AcChoEase activity was only slightly higher, and the proportions of molecular forms were similar, with 3-day and 4-day denervated ganglia (Fig. 3C,   solid line) .
Effects of Gly-Gln on the AcChoEase Content of Cultured SCG Sections. Preliminary experiments with sections of SCG excised 24 hr after denervation indicated that Gly-Gln in the range of i0-7-_1 -5 M produced enhancement of the G1, G2, and G4 peaks of AcChoEase, with a maximum effect at 10 -5 M; at 10-4 M, the effect was inhibitory. When sections of nondenervated ganglia were cultured under identical conditions, 10-5 M Gly-Gln was inhibitory, but enhancement was Neurobiology: Koelle et obtained at 106 M (data not shown). The probable reason for this shift is considered in the Discussion. In all subsequent experiments done with denervated SCG, 10-M Gly-Gln was used unless otherwise noted.
Total AcChoEase. In the absence of preliminary treatment with 217 AO, the presence of Gly-Gln in the culture medium produced an increase of -35% in the activity of the three forms-4, G2, and G1-for sections of SCG excised 1 day after denervation and cultured for 24 hr ( Fig. 2A, broken  line) . In ganglia excised 3 days after denervation, the total activity was increased by '20%, and that of the three forms (evaluated from the maximum of each peak) was 125% (G1), 110% (G2), and 90% (G4) (Fig. 2B, broken line) . At 5 days after denervation, the corresponding values were 235%, 140%, and 125% (Fig. 2C, broken line) ; when culture was extended to 44 hr, they were 185%, 115%, and 105%, respectively (Fig. 2D, broken line) . The values obtained when only 10-6 M Gly-Gln was added, in the same conditions, were consistently indistinguishable from controls (data not shown).
Newly synthesized AcChoEase. The only instance in which Gly-Gln produced predominant enhancement of the G4 peak was in 217 AO-treated sections of 1-day postdenervation SCG cultured for 24 hr (Fig. 3A, broken line) . When culture of similarly treated sections was extended to 48 hr, the pattern was reversed; enhancement produced by GlyGln over controls was 160% for G,, 135% for G2, and 120% for G4 (Fig. 3B, broken line) . In SCG excised 4 days after denervation, when AcChoEase synthesis was markedly reduced, the values for Gly-Gln-treated versus control sections were 155% (Ga), 120% (G2), and 100% (G4) (Fig. 3C , broken line). For 5-day postdenervation sections, the corresponding values were 220% (G0), 150% (G2), and 115% (G4) (Fig. 3D, broken line) .
Effects of Cat Nervous Tissue Extract on AcChoEase. In a few experiments, we examined the effect of dialyzed (molecular weight cutoff 1000) aqueous extract of cat brain, spinal cord, and sciatic nerves. When we incorporated an amount corresponding to a final concentration of 17 mg of wet weight of tissue per ml of culture medium with sections of 1-day postdenervation SCG, cultured for 24 hr, the activities of all three major peaks of AcChoEase were increased to 125-135% of controls. With an amount corresponding to 50 mg/ml, the peaks were 175%o (G0), 155% (G2), and 150% (G4) of controls (data not shown). With an amount corresponding to 100 mg/ml, we observed a decrease of all three peaks.
Effect of Gly-Gin on Other Enzymes. In the series of experiments described above, we examined the activities of BtChoEase and of the metabolic enzymes LDH and enolase in 217 AO-treated or untreated SCG sections, cultured with or without Gly-Gln. Whereas 217 AO produced near-total inhibition of BtChoEase, it did not modify the LDH and enolase activities, as expected; the presence of Gly-Gln did not significantly modify the activities of LDH or enolase in any of the conditions used (data not shown).
We found that 217 AO reduced by about 35% the amount of AcChoEase or BtChoEase released in the medium by nondenervated SCG sections after 24 hr culture. Gly-Gln did not modify the activities of AcChoEase, BtChoEase, or of the metabolic enzymes LDH and enolase recovered in the culture media of 217 AO-treated or untreated SCG sections, indicating that it did not affect their release from cells.
DISCUSSION
In this work we attempted to reproduce in vitro the previously observed effect of Gly-Gln or endogenous neurotrophic factor in vivo. This approach should allow us to address the question of the metabolic stage at which the effect takes place, in biosynthesis (transcription, translation, acquisition of catalytic activity, polymerization of monomers into complex forms) or in degradation of the enzyme.
Preganglionic denervation results in a multitude of changes, which have undoubtedly been only partially described. Notable here was the fall in the ability of sections to maintain and synthesize AcChoEase in culture. The reduction was moderate in sections of SCG excised 1 day after denervation, but marked after 3 to 5 days. The same sequence occurs in vivo; at 1 day after denervation the AcChoEase content of the cat SCG is -85% of the normal value, and by 3 days it has fallen to 15% (1, 2) . Gly-Gln has been found to oppose the AcChoEase decrease in culture, but somewhat less effectively than after perfusion in vivo (4, 6) .
In these experiments, Gly-Gln did not modify the content of the metabolic enzymes LDH or enolase in the cultured SCG sections or the amount of these enzymes in the culture medium. It therefore did not exert a general nonspecific influence on cell survival or protein synthesis. Although we saw some enhancement of total AcChoEase activity, the most significant difference between Gly-Gln-treated cultures r Neurobiology: Koelle et al. 8( 10 20 30 and controls was in the proportions of AcChoEase molecular forms. Recent evidence (13) has confirmed the long-held assumption that the active monomeric globular G, form of AcChoEase is assembled into the polymeric globular (G2, G4) and asymmetric (A4, A8, A12) forms. It was postulated earlier that Gly-Gln acts by regulating the polymerization of monomers into complex forms (4, 7). However, most of the present findings are not consistent with this notion. In all experiments done with SCG excised 3-5 days after denervation, with or without initial inactivation of residual AcChoEase, Gly-Gln produced predominantly an enhancement of the G1 peak, with progressively less effect on the G2 and G4 peaks. The A12 peak was too small to permit detection of any significant effect. This pattern was reversed only in sections of 1-day postdenervation SCG treated with 217 AO and cultured for 24 hr; after 48 hr in culture the chief effect was on the G1 peak. In sections of 1-day postdenervation SCG not treated with 217 AO, Gly-Gln produced a minor increase of AcChoEase activity with no change in the proportions of the G1, G2, and G4 forms. A number of factors might account for the apparent inconsistencies that were found immediately after denervation.
A study of the metabolism of AcChoEase forms in the murine neuronal cell line T28 (14) has shown that their relationship is complex because of the existence of multiple pools, particularly of the G, form (15) . AcChoEase is first synthesized as an inactive precursor, which is then converted into an enzymatically active G1 form, most of which is rapidly degraded with only a small fraction being assembled into polymeric forms (15) . The existence of an inactive precursor and of a high rate of degradation was also established in the case of primary cultures of chick myotubes (16) . It was surpising that in all our cultured sections the predominant AcChoEase form was G4. so that the sedimentation profile resembled qualitatively more that of normal SCG than that of immediately prepared homogenates of 3-or 4-day preganglionically denervated SCG, where G4 was considerably decreased but G2 and G1 were much less modified (9) .
In 1-day postdenervation SCG, although the AcChoEase contents are only slightly reduced, in vivo and in 24-hr cultured sections the ability to synthesize new AcChoEase in culture was found to be reduced to 40% of normal. The situation in 1-day postdenervation SCG is probably complicated further by the presence of a significant residual concentration of endogenous neurotrophic factor. It is not known whether the hypothetical neurotrophic factor released by the preganglionic fibers is identical to that demonstrated in the central nervous system extract (1, 3) or whether either is identical with Gly-Gln, which is present in the central nervous system (17) . Nevertheless, their similar effects in maintaining ganglionic AcChoEase might be expected to summate. Residual neurotrophic factor could also account for the shift of a magnitude between denervated and normal SCG in the concentration of Gly-Gln that produced enhancement (10-5 M going to 10-6 M) and reduction (10-4 M going to i0-' M) in the AcChoEase contents of cultured sections. In the normal SCG, an optimal concentration of endogenous factor would be expected to be present at the time of excision.
The inhibitory effect of high concentrations of Gly-Gln on the AcChoEase contents of denervated SCG was also found in vivo (6) . It is noteworthy that in those experiments maximal enhancement was obtained with intraarterial infusion of 3 x 10-6 M Gly-Gln, and reduction of AcChoEase activity was obtained with 10-4 M-i.e., essentially the concentrations found here to produce similar effects in vitro.
However, this apparent correspondence is fortuitous. The concentrations expressed for the in vivo experiments represent those in the solutions that were slowly infused into the common carotid artery over 24 hr; with dilution of these solutions in the bloodstream, concentrations are therefore one to two orders of magnitude higher than the concentrations reaching the SCG.
Because it appears unlikely that Gly-Gln enhances the polymerization of G1 AcChoEase to polymeric forms, at what stage does Gly-Gln act to maintain the enzyme in denervated SCG? Protein synthesis involves multiple steps, including transcription, translation, and post-translational modifications. The results presented here suggest that GlyGln acts specifically on the synthesis or activation of AcChoEase, but not on polymerization of G1 into heavier forms-perhaps by combining with an effector protein; our results do not permit identification of the level of this action.
The failure to obtain a clear effect of Gly-Gln on AcChoEase in cultures of rat SCG is not altogether surprising. In contrast to the cat (18) , the cytoplasm of nearly all the adrenergic ganglion cells of rat SCG contains substantial concentrations of AcChoEase (19) . This is reflected by the presence in the rat ganglion of approximately equal concentrations of the cytoplasmic G1 and membrane-bound G4 forms (20) . After preganglionic denervation, the rat SCG develops a temporary loss of only approximately half the normal content of AcChoEase, and the original level is practically restored within a few days in the absence of reinnervation (20) . Thus, effects comparable to those described here would be extremely difficult to detect.
